84-2312-49 [取扱停止]Cdc2 (Cyclin-Dependent Kinase 1, Cell Division Control Protein 2 Homolog, Cell Division Protein Kinase 1, p34 Protein Kinase, CDK1, CDC2, CDC28A, CDKN1, P34CDC2) 100ul 221564
特徴
- Cdc2, an evolutionarily conserved serine/threonine-specific protein kinase, is essential in the cell cycle transition from G2 to M phase.
- Cdc2 is regulated by association with B-type cyclins and by reversible phosophorylation.
- Cyclin B binding facilitates the phosphorylation of Cdc2 p34 on three regulatory sites: threonine 14, tyrosine 15, and threonine 161.
- In higher eukaryotes, Cdc2 is negatively regulated by phosphorylation of two residues located in the ATP-binding site, Thr 14 and Tyr 15.
- Cdc2 is positively regulated by the cyclin-dependent phosphorylation of Thr 161.
- Both phosphorylation and de- phosphorylation at Thr 161 are required for progression through the cell cycle.
- Applications:Suitable for use in Western Blot.
- Other applications not tested.
- Recommended Dilution:Western Blot: 1:500-1:1000Optimal dilutions to be determined by the researcher.
- Storage and Stability:May be stored at 4°C for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20°C.
- Aliquots are stable for 12 months after receipt.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size:100ul
- Host:rabbit
- Source Antibody:human
- Grade:Affinity Purified
- Purity:Purified by immunoaffinity chromatography.
- Form:Supplied as a liquid PBS, 0.05% sodium azide, pH 7.2.
- Specificity:Recognizes endogenous levels of Cdk1/Cdc2. Species Crossreactivity: Human, mouse, rat
- Isotype:IgG
- Calc Applications Abbrev:WB
- Calc Crossreactivity:Hu Mo Rt
- Immunogen:Synthetic peptide corresponding to amino acids 771-820 of Human Cdk1/Cdc2.
- Shelf Life:1year
- Swiss Prot Number:P06493
- EU Commodity Code:30021010
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]